A note to anti-vaxxers

By

Erika Fry

By

Erika Fry

February 19, 2015, 6:30 AM ET

Photograph by Freya ingrid Morales — Bloomberg via Getty Images

For drugmakers, treating diseases is far more lucrative than preventing them.

This story is from the March 1, 2015 issue of Fortune.

About the Author

By Erika Fry

See full bio

Latest in Features

Investing Warren Buffett

Warren Buffett’s blind spot: Did the digital economy leave him behind?

By Adam SeesselDecember 30, 2025

AI OpenAI

Inside OpenAI’s fragile lead in the AI race, and the 8-week ‘code red’ to fend off a resurgent Google

By Jeremy Kahn, Alexei Oreskovic and Lee CliffordDecember 17, 2025

Features The Boring Company

Two firefighters suffered chemical burns in a Boring Co. tunnel. Then the Nevada Governor’s office got involved, and the penalties disappeared

By Jessica Mathews and Leo SchwartzNovember 12, 2025

CoreWeave executives pose in front of the Nasdaq building on the day of the company's IPO.

AI Data centers

Data-center operator CoreWeave is a stock-market darling. Bears see its finances as emblematic of an AI infrastructure bubble

By Jeremy Kahn and Leo SchwartzNovember 8, 2025

$Libery Energy's hydraulic fracturing, or frac, spreads are increasingly electrified with natural gas power, a technology now translating to powering data centers.$

Energy

AI’s insatiable need for power is driving an unexpected boom in oil-fracking company stocks

By Jordan BlumOctober 23, 2025

Politics

Huge AI data centers are turning local elections into fights over the future of energy

By Sharon GoldmanOctober 22, 2025

Latest in Features

Finance